Evidence map›Paper›PMID 37570799›Full record

ArticleMolecules (Basel, Switzerland)2023

The Copper(II)-Thiodiacetate (tda) Chelate as Efficient Receptor of N9-(2-Hydroxyethyl)Adenine (9heade): Synthesis, Molecular and Crystal Structures, Physical Properties and DFT Calculations of [Cu(tda)(9heade)(H

Carmen Rosales-Martínez, Antonio Matilla-Hernádez, Duane Choquesillo-Lazarte, Antonio Frontera, Alfonso Castiñeiras, Juan Niclós-Gutiérrez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. H(N3)dap (Hdap = 2,6-Diaminopurine) Recognition by CuMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Carmen Rosales-MartínezDepartment of Inorganic Chemistry, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.
Antonio Matilla-HernádezDepartment of Inorganic Chemistry, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.ORCID 0000-0001-5513-1815
Duane Choquesillo-LazarteLaboratorio de Estudios Cristalográficos, IACT, CSIC-Universidad de Granada, Avda. de las Palmeras 4, Armilla, 18100 Granada, Spain.ORCID 0000-0002-7077-8972
Antonio FronteraDepartament de Química, Universitat de les Illes Balears, Crta. de Valldemossa km 7.5, 07122 Palma de Mallorca, Spain.ORCID 0000-0001-7840-2139
Alfonso CastiñeirasDepartment of Inorganic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-5070-5936
Juan Niclós-GutiérrezDepartment of Inorganic Chemistry, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-8882-640X
Universidad de Granada · ESUniversidade de Santiago de Compostela · ESUniversitat de les Illes Balears · ES

Funding

MICINN B-FQM-478-UGR20MICINN PGC2018-102047-B-I00MICIU/AEI PID2020-115637GB-I00 FEDER
6 · The paper itself

Abstract

Considering that Cu(tda) chelate (tda: dithioacetate) is a receptor for adenine and related 6-aminopurines, this study reports on the synthesis, molecular and crystal structures, thermal stability, spectral properties and DFT calculations related to [Cu(tda)(9heade)(H

Indexed as

chelate-nucleoside recognitioncopper(II)DFT calculationsmolecular and crystal structurephysical propertiessynthetic adenine nucleosidethiodiacetate chelatewater-mediated interligand interactions

Identifiers

PMID37570799
PMCPMC10420684
OpenAlexW4385492406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.